BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37967928)

  • 1. First-reported case of vaginal late recurrence of Wilms tumor treated with complete pelvic exenteration.
    Pizzuti G; Quijano Y; Vicente E; Caruso R
    BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37967928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration.
    Donati OF; Lakhman Y; Sala E; Burger IA; Vargas HA; Goldman DA; Andikyan V; Park KJ; Chi DS; Hricak H
    Eur Radiol; 2013 Oct; 23(10):2906-15. PubMed ID: 23652852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic Exenteration in Gynecologic Cancer: La Paz University Hospital Experience.
    Moreno-Palacios E; Diestro MD; De Santiago J; Hernández A; Zapardiel I
    Int J Gynecol Cancer; 2015 Jul; 25(6):1109-14. PubMed ID: 25853383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
    World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Outcomes of perisurgery and short-time follow-up of pelvic exenteration for 17 cases with locally recurrent cervical cancer].
    Deng H; Wang JL; Wang ZQ; Li XW; Hu H; Yang B; Zhang XM; Shen K; Guo P; Liang B
    Zhonghua Fu Chan Ke Za Zhi; 2020 Apr; 55(4):259-265. PubMed ID: 32375433
    [No Abstract]   [Full Text] [Related]  

  • 6. Pelvic exenteration for primary and recurrent gynaecological malignancies.
    de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the risk of local recurrence after laparoscopic transperitoneal radical nephrectomy in children with Wilms tumours? Analysis of a local series and review of the literature.
    Bouty A; Burnand K; Nightingale M; Roberts A; Campbell M; O'Brien M; Heloury Y
    J Pediatr Urol; 2018 Aug; 14(4):327.e1-327.e7. PubMed ID: 29705138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative Pelvic Exenteration for Pelvic Recurrence Invading the Sciatic Foramen with Chronic Cutaneous Perineal Fistula after Radical Surgery for Cervical Cancer: A Case Report.
    Bacalbasa N; Balescu I
    Anticancer Res; 2015 Sep; 35(9):4877-80. PubMed ID: 26254382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic assessment improves case selection for exenterative surgery in recurrent cervical and endometrial cancer.
    Heath OM; Bryan SJ; Sohaib A; Barton DPJ
    J Obstet Gynaecol; 2021 Nov; 41(8):1252-1256. PubMed ID: 33646894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should pelvic exenteration for symptomatic relief in gynaecology malignancies be offered?
    Pathiraja P; Sandhu H; Instone M; Haldar K; Kehoe S
    Arch Gynecol Obstet; 2014 Mar; 289(3):657-62. PubMed ID: 24026090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indications for primary and secondary exenterations in patients with cervical cancer.
    Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
    Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database.
    Brok J; Lopez-Yurda M; Tinteren HV; Treger TD; Furtwängler R; Graf N; Bergeron C; van den Heuvel-Eibrink MM; Pritchard-Jones K; Olsen ØE; de Camargo B; Verschuur A; Spreafico F
    Lancet Oncol; 2018 Aug; 19(8):1072-1081. PubMed ID: 29960848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing role for extended resections in an era of advanced radiotherapy techniques and novel therapies in gynaecological malignancy.
    McBain RD; McGauran MFG; Tran KH; Au-Yeung G; Khaw PYL; McNally OM
    Eur J Surg Oncol; 2022 Nov; 48(11):2308-2314. PubMed ID: 36184421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Total pelvic exenteration in vaginal cancer--case report].
    Olejek A; Arendt J; Olszak-Wasik K; Waniczek D; Zamłyński J; Horák S; Nowak L; Kozak-Darmas I
    Ginekol Pol; 2013 Feb; 84(2):142-6. PubMed ID: 23668062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A qualitative study of the development of a multidisciplinary case conference review methodology to reduce involved margins in pelvic exenteration surgery for recurrent rectal cancer.
    van Ramshorst GH; O'Shannassy S; Brown WE; Kench JG; Solomon MJ
    Colorectal Dis; 2018 Nov; 20(11):1004-1013. PubMed ID: 29920909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic exenteration for recurrent or persistent cervical cancer: experience of five years at the National Cancer Institute in Mexico.
    Terán-Porcayo MA; Zeichner-Gancz I; del-Castillo RA; Beltrán-Ortega A; Solorza-Luna G
    Med Oncol; 2006; 23(2):219-23. PubMed ID: 16720922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal cancer as a late complication of radiotherapy for endometrial cancer and ileo-perineal fistula after total pelvic exenteration.
    Comba C; Topaktas M; Bozkurt H; Erbin A; Ozdogan B; Demir O
    J Gynecol Oncol; 2021 Jul; 32(4):e63. PubMed ID: 34085797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined laparoscopic and transperineal endoscopic total pelvic exenteration for the vaginal stump recurrence of cervical cancer.
    Ohno R; Matsumoto Y; Nagano H; Komono A; Aisu N; Yoshimatsu G; Hasegawa S
    J Gynecol Oncol; 2022 Jan; 33(1):e16. PubMed ID: 34910397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer.
    Tanaka S; Nagase S; Kaiho-Sakuma M; Nagai T; Kurosawa H; Toyoshima M; Tokunaga H; Otsuki T; Utsunomiya H; Takano T; Niikura H; Ito K; Yaegashi N
    Int J Clin Oncol; 2014 Feb; 19(1):133-8. PubMed ID: 23404487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of gynecologic oncology patients in King Chulalongkorn Memorial Hospital - complications and outcome of pelvic exenteration.
    Oranratanaphan S; Termrungruanglert W; Sirisabya N
    Asian Pac J Cancer Prev; 2013; 14(4):2529-32. PubMed ID: 23725169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.